Logo

$3.3B Spin-off – Global Clinical Research Company

Delivering pre-spin IT separation, Day 1 readiness, and secure data migration to support a smooth and compliant spin-off.

Industry

Pharma & Biotech

Client

Medium Enterprise

Engagement Duration

6–12 months

Location

Raleigh, NC

$3.3B Spin-off – Global Clinical Research Company-banner

The Challenge

A global clinical research company was preparing for a $3.3B spin-off. The initiative required complex pre-spin IT separation, including hosting, networking, collaboration tools, and critical data management — all while ensuring compliance, security, and business continuity by Day 1.

Our Approach

  • Developed a pre-spin IT separation plan, including infrastructure hosting and networking.
  • Executed a Microsoft 365 (M365) separation strategy to segregate collaboration tools and data.
  • Built Day 1 readiness plans, including Transition Service Agreements (TSAs) and exit strategies to ensure minimal disruption.

In-depth Details

  • Migrated unstructured data from 30,000 Teams sites into 4,000 mapped drives, significantly improving data organization and security.
  • Designed and implemented secure networking and hosting environments to support the new standalone entity.
  • Managed change and communication planning to prepare stakeholders for Day 1 cutover.
  • Established clear TSA agreements and exit plans to minimize operational risk and accelerate independence.

$3.3B

Transaction value

6–12

Engagement Duration

30,000

Teams sites Migrated

4,000

mapped drives

securely and efficiently

Result

Achieved a smooth, compliant, and timely IT separation. Enabled Day 1 operational readiness with secure infrastructure and collaboration environments. Delivered a scalable data management approach that reduced complexity and supported future growth.

quote

Strategy MA was a game-changer for us. Their expertise in M&A and tech strategy helped us navigate a complex integration. They didn’t just advise, they became an extension of our team and delivered results beyond expectations. Highly recommend them for real impact

Jack Wilnor

CEO